Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aquinox Pharmaceuticals Inc (AQXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7954
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company’s lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a regualting component of the PI3K pathway. Its discovery platform is based on the screening of a natural product library of compounds to identify potential SHIP1 activators. Aquinox undertakes clinical trials of several drugs for the treatment of chronic obstructive pulmonary disease, bladder pain syndrome interstitial cystitis, allergic asthma and atopic dermatitis, among others. The company has operations in Canada and the US. Aquinox is headquartered in Vancouver, British Columbia, Canada.

Aquinox Pharmaceuticals Inc (AQXP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Aquinox Pharma Raises US$18 Million In Series C Financing 10
Licensing Agreements 11
Astellas Pharma Enters into Licensing Agreement with Aquinox Pharma 11
Equity Offering 12
Aquinox Pharma Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 12
Aquinox Pharma Plans to Raise up to USD171.4 Million in Public Offering of Shares 13
Aquinox Pharma Raises USD57.7 Million in Public Offering of Shares 14
Aquinox Pharma Raises USD98 Million in Public Offering of Shares 16
Aquinox Pharma to Raise USD25 Million in Public Offering of Shares 17
Aquinox Pharma Completes IPO For US$53 Million 18
Aquinox Pharmaceuticals Inc – Key Competitors 20
Aquinox Pharmaceuticals Inc – Key Employees 21
Aquinox Pharmaceuticals Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 08, 2018: Aquinox Pharmaceuticals announces second quarter 2018 financial results 23
May 08, 2018: Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results 25
Mar 12, 2018: Aquinox Pharmaceuticals Announces Year End 2017 Financial Results 27
Aug 08, 2017: Aquinox Pharmaceuticals Announces Second Quarter 2017 Financial Results 28
May 09, 2017: Aquinox Pharmaceuticals Announces First Quarter 2017 Financial Results 30
Mar 09, 2017: Aquinox Pharmaceuticals Announces Year End 2016 Financial Results 31
Corporate Communications 33
Mar 27, 2017: Aquinox Announces Appointment of Dr. Kelvin Neu and Dr. Richard Levy to Board of Directors 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aquinox Pharma Raises US$18 Million In Series C Financing 10
Astellas Pharma Enters into Licensing Agreement with Aquinox Pharma 11
Aquinox Pharma Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 12
Aquinox Pharma Plans to Raise up to USD171.4 Million in Public Offering of Shares 13
Aquinox Pharma Raises USD57.7 Million in Public Offering of Shares 14
Aquinox Pharma Raises USD98 Million in Public Offering of Shares 16
Aquinox Pharma to Raise USD25 Million in Public Offering of Shares 17
Aquinox Pharma Completes IPO For US$53 Million 18
Aquinox Pharmaceuticals Inc, Key Competitors 20
Aquinox Pharmaceuticals Inc, Key Employees 21
Aquinox Pharmaceuticals Inc, Other Locations 22

List of Figures
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aquinox Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bilim Pharmaceuticals:企業の戦略的SWOT分析
    Bilim Pharmaceuticals - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Dow Silicones Corp:企業の戦略的SWOT分析
    Dow Silicones Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Fortune Electric Co Ltd (1519):企業の財務・戦略的SWOT分析
    Summary Fortune Electric Co Ltd (Fortune Electric) is a power company that manufactures and markets transformers and accessories. The company's products include distribution transformers, power transformers, cast resin transformers and amorphous metal alloy core transformers, among others. It offers …
  • Exelon Corporation:企業の戦略・SWOT・財務情報
    Exelon Corporation - Strategy, SWOT and Corporate Finance Report Summary Exelon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cisco Systems Inc (CSCO):電力:M&Aディール及び事業提携情報
    Summary Cisco Systems Inc (Cisco) designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. The company’s products are blade switches, analytics and automation software, application networking services, interfaces and modules, optical networking, security, s …
  • STATS UK Ltd:企業の戦略的SWOT分析
    STATS UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fresenius Kabi AG:企業の戦略的SWOT分析
    Fresenius Kabi AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bayer AG (BAYN):企業の財務・戦略的SWOT分析
    Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • SimCorp AS (SIM):企業の財務・戦略的SWOT分析
    SimCorp AS (SIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Randall & Quilter Investment Holdings Ltd.:企業のM&A・事業提携・投資動向
    Randall & Quilter Investment Holdings Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Randall & Quilter Investment Holdings Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • International Personal Finance plc:企業の戦略・SWOT・財務情報
    International Personal Finance plc - Strategy, SWOT and Corporate Finance Report Summary International Personal Finance plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Mitsui Fudosan Co., Ltd.:企業の戦略・SWOT・財務情報
    Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Spar Nord Bank A/S:企業の戦略・SWOT・財務情報
    Spar Nord Bank A/S - Strategy, SWOT and Corporate Finance Report Summary Spar Nord Bank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Insperity Inc (NSP):企業の財務・戦略的SWOT分析
    Insperity Inc (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Fcmb Group Plc
    Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report Summary Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • TOA Corporation:企業の戦略・SWOT・財務分析
    TOA Corporation - Strategy, SWOT and Corporate Finance Report Summary TOA Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • St. Jude Medical LLC-医療機器分野:企業M&A・提携分析
    Summary St. Jude Medical LLC (SJM), a part of Abbott Laboratories, is a medical device company. It develops and manufactures devices for the cardiac rhythm management, cardiovascular, cardiac surgery and atrial fibrillation therapy areas, and implantable neurostimulation devices for the management o …
  • Retrophin Inc (RTRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Retrophin Inc (Retrophin) is a biopharmaceutical company that discovers, develops, acquires and commercializes drugs for the treatment of rare diseases. The company’s products include thiola, chenodal and cholbam. It develops drugs for various catastrophic diseases. Retrophin’s pipeline prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆